256 related articles for article (PubMed ID: 6208278)
1. Cell contact-mediated macrophage activation for antileishmanial defense. I. Lymphocyte effector mechanism that is contact dependent and noncytotoxic.
Panosian CB; Sypek JP; Wyler DJ
J Immunol; 1984 Dec; 133(6):3358-65. PubMed ID: 6208278
[TBL] [Abstract][Full Text] [Related]
2. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction.
Sypek JP; Panosian CB; Wyler DJ
J Immunol; 1984 Dec; 133(6):3351-7. PubMed ID: 6333458
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation for antileishmanial defense by an apparently novel mechanism.
Wyler DJ; Beller DI; Sypek JP
J Immunol; 1987 Feb; 138(4):1246-9. PubMed ID: 3100630
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes.
Nacy CA; Meltzer MS; Fortier AH
J Immunol; 1984 Dec; 133(6):3344-50. PubMed ID: 6491291
[TBL] [Abstract][Full Text] [Related]
5. Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: dissociation of these microbicidal effector activities in vitro.
Hockmeyer WT; Walters D; Gore RW; Williams JS; Fortier AH; Nacy CA
J Immunol; 1984 Jun; 132(6):3120-5. PubMed ID: 6725948
[TBL] [Abstract][Full Text] [Related]
6. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
[TBL] [Abstract][Full Text] [Related]
7. Antigen recognition by effector T cells in antileishmanial defense.
Sypek JP; Panosian CB; Wyler DJ
J Infect Dis; 1985 Nov; 152(5):1057-63. PubMed ID: 2413143
[TBL] [Abstract][Full Text] [Related]
8. Resistance to macrophage-mediated killing as a factor influencing the pathogenesis of chronic cutaneous leishmaniasis.
Scott P; Sacks D; Sher A
J Immunol; 1983 Aug; 131(2):966-71. PubMed ID: 6863939
[TBL] [Abstract][Full Text] [Related]
9. Studies on intracellular killing of Leishmania major and lysis of host macrophages by immune lymphoid cells in vitro.
Pham TV; Mauël J
Parasite Immunol; 1987 Nov; 9(6):721-36. PubMed ID: 2448731
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation to kill Leishmania tropica: defective intracellular killing of amastigotes by macrophages elicited with sterile inflammatory agents.
Hoover DL; Nacy CA
J Immunol; 1984 Mar; 132(3):1487-93. PubMed ID: 6363543
[TBL] [Abstract][Full Text] [Related]
11. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes.
Nacy CA
J Immunol; 1984 Jul; 133(1):448-53. PubMed ID: 6202789
[TBL] [Abstract][Full Text] [Related]
12. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
Titus RG; Lima GC; Engers HD; Louis JA
J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
[TBL] [Abstract][Full Text] [Related]
13. Macrophage activation to kill Leishmania tropica: kinetics of macrophage response to lymphokines that induce antimicrobial activities against amastigotes.
Oster CN; Nacy CA
J Immunol; 1984 Mar; 132(3):1494-500. PubMed ID: 6363544
[TBL] [Abstract][Full Text] [Related]
14. Cell contact-mediated macrophage activation for antileishmanial defence: mapping of the genetic restriction to the I region of the MHC.
Sypek JP; Wyler DJ
Clin Exp Immunol; 1985 Dec; 62(3):449-57. PubMed ID: 3936653
[TBL] [Abstract][Full Text] [Related]
15. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
Prina E; Lang T; Glaichenhaus N; Antoine JC
J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
[TBL] [Abstract][Full Text] [Related]
16. Th2 lymphocyte clone can activate macrophage antileishmanial defense by a lymphokine-independent mechanism in vitro and can augment parasite attrition in vivo.
Sypek JP; Matzilevich MM; Wyler DJ
Cell Immunol; 1991 Mar; 133(1):178-86. PubMed ID: 1825032
[TBL] [Abstract][Full Text] [Related]
17. Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation.
Kram D; Thäle C; Kolodziej H; Kiderlen AF
J Immunol Methods; 2008 Apr; 333(1-2):79-88. PubMed ID: 18313691
[TBL] [Abstract][Full Text] [Related]
18. Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon.
Titus RG; Kelso A; Louis JA
Clin Exp Immunol; 1984 Jan; 55(1):157-65. PubMed ID: 6198115
[TBL] [Abstract][Full Text] [Related]
19. Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection.
Davis CE; Belosevic M; Meltzer MS; Nacy CA
J Immunol; 1988 Jul; 141(2):627-35. PubMed ID: 3133412
[TBL] [Abstract][Full Text] [Related]
20. Recognition of protozoan parasites by murine T lymphocytes. II. Role of the H-2 gene complex in interactions between antigen-presenting macrophages and Leishmania-immune T lymphocytes.
Louis JA; Moedder E; MacDonald HR; Engers HD
J Immunol; 1981 May; 126(5):1661-6. PubMed ID: 6452473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
